Malignant Solid Neoplasm: Clinical Trials

4 trials for Malignant Solid Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 active not recruiting. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Active not recruiting 4

Follow Malignant Solid Neoplasm: new trials by email Literature Review of Malignant Solid Neoplasm trials Research Report on Malignant Solid Neoplasm

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment
Behavioral Intervention, Electronic Health Record Review, Quality-of-Life Assessment - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Phase 3Active not recruitingUniversity of Rochester NCORP Research Base4002021-06-242026-04-24
Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study
Educational Intervention, FitBit, Goal Setting - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Phase 3Active not recruitingChildren's Oncology Group3872020-12-072026-08-06
Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer Patients
Fentanyl Citrate Buccal Tablet, Morphine, Physical Performance Testing - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Phase 3Active not recruitingM.D. Anderson Cancer Center1502020-10-232026-08-11
Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors
Biospecimen Collection, Bupropion Hydrochloride Controlled-release, Placebo Administration - Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Phase 3Active not recruitingUniversity of Rochester NCORP Research Base4222019-06-272026-09-30

Narrower conditions

Hematologic Neoplasms (3)

Broader conditions

Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)

Interventions

Behavior Therapy (1)  ·  Bupropion (1)  ·  Early Intervention, Educational (1)  ·  Educational Status (1)  ·  Exercise Test (1)  ·  Fentanyl (1)  ·  Health Promotion (1)  ·  Methods (1)  ·  Morphine (1)  ·  Organizational Objectives (1)  ·  Specimen Handling (1)

Sponsors

University of Rochester NCORP Research Base (2)  ·  Children's Oncology Group (1)  ·  M.D. Anderson Cancer Center (1)

Countries

United States (4)  ·  Canada (1)

Top investigators

David Hui (1)  ·  Heather S Jim (1)  ·  Nina S Kadan-Lottick (1)  ·  Oxana Palesh, PhD (1)

Results publications

PMID 39079612, PMID 41115797, PMID 41170811

NIH funding

R01CA214647 (2), UG1CA189961 (2), R01CA231471 (1), R01CA239714 (1), U01CA246665 (1), UG1CA189955 (1)